Form 4 for CGEM Cullinan Therapeutics, Inc.
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-20 · accession 0001193125-26-064256 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-02-23 | 2026-02-20 | CGEM | Michaelson Jennifer | CSO | S - Sale+OE | $14.08 | -11.7K | 182.0K | -6% | -$165.4K |
| DT | 2026-02-23 | 2026-02-20 | CGEM | Michaelson Jennifer | CSO | M - OptEx | $4.30 | +8,000 | 190.0K | +4% | +$34.4K |
| DT | 2026-02-23 | 2026-02-20 | CGEM | Michaelson Jennifer | CSO | M - OptEx | $0.00 | -8,000 | 125.0K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | S | D | 8,000 | $14.30 | 181,977 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-20 | M | A | 8,000 | $4.30 | 189,977 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-20 | S | D | 3,742 | $13.62 | 181,977 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-02-20 | M | D | 8,000 | $0.00 | 124,987 | D | $4.30 · — to 2030-10-28 | 8,000 Common Stock | (F3) 25% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter. |